New combo therapy aims to help patients with rare blood disease stop steroids
Disease control
Not yet recruiting
This study looks at whether adding sirolimus to standard steroid treatment helps adults with newly diagnosed mild autoimmune hemolytic anemia (AIHA) achieve long-term remission without needing ongoing medication. About 216 participants will be randomly assigned to receive either …
Phase: NA • Sponsor: Chen Miao • Aim: Disease control
Last updated May 15, 2026 11:53 UTC